C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/57 (2006.01) C07K 14/46 (2006.01) C12N 9/64 (2006.01) C12P 21/00 (2006.01) C12P 21/06 (2006.01)
Patent
CA 2083702
2083702 9218516 PCTABS00016 There is provided by the invention a novel composition comprising, in at least partially purified form, an endopeptidase endogenous to biological cells. The endopeptidase is characterized by having a molecular weight of about 110,000 daltons as measured by SDS PAGE; by being substantially insensitive to PMSF, TPCK, E-64, leupeptin, bacitracin, phosphoramidon and pepstatin; by being substantially inhibited by EDTA and 1,10-phenanthroline; and by being capable of cleaving peptide substrate comprising an alpha helical structural of at least about twelve to fourteen amino acids wherein said helix has a hydrophobic face and a hydrophilic face, said cleavage occurring amino terminal to a lysine or arginine residue on the hydrophilic face positioned within the context of at least four nonpolar amino acids substantially aligned along the hydrophobic face of the helix.
Resnick Nicole M.
Zasloff Michael A.
Children's Hospital Of Philadelphia (the)
Smart & Biggar
LandOfFree
Endopeptidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endopeptidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endopeptidase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1573359